FIELD: chemistry.
SUBSTANCE: invention relates to a compound which is a covalent conjugate of interferon with a polytriethylenediamine N-oxide derivative, and can be used to produce antiviral preparations, having antiviral and immunotropic activity. The compound is a novel stable antiviral interferon preparation with prolonged action.
EFFECT: owing to detoxicant and antioxidant properties of the carrier, the preparation has a wide range of pharmacological applications.
6 cl, 1 dwg, 2 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONJUGATE OF GLYCOPROTEIN, POSSESSING ERYTHROPOIETIN ACTIVITY, WITH POLY-1,4-ETHYLENEPIPERAZINE N-OXIDE DERIVATIVES (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CONJUGATE OBTAINING | 2013 |
|
RU2556378C2 |
| NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON | 2010 |
|
RU2447083C1 |
| MEDICINAL AGENT BASED ON MODIFIED ALPHA INTERFERON WITH PROLONGED THERAPEUTIC ACTION | 2008 |
|
RU2382048C1 |
| PEG-MODIFIED HUMAN INTERFERON β-1a MOLECULE WITH ANTIVIRAL, IMMUNOMODULATORY AND ANTIPROLIFERATIVE ACTIVITY, WITH IMPROVED STABILITY, REDUCED IMMUNOGENICITY, IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS, SUITABLE FOR MEDICAL USE, AND IMMUNOBIOLOGICAL FORMULATION BASED THEREON | 2013 |
|
RU2576372C2 |
| PAGYLATED INTERFERON AGAINST VIRAL INFECTION | 2004 |
|
RU2311930C2 |
| PEGYLATED RECOMBINANT CONSENSUS INTERFERON VERSION CONJUGATE AND PREPARATION METHOD AND USE THEREOF | 2011 |
|
RU2575796C9 |
| PEG DENDRIMER WITH FOUR BRANCHES FOR CONJUGATION WITH PROTEINS AND PEPTIDES | 2006 |
|
RU2409389C2 |
| METHOD OF SYNTHESISING CONJUGATES OF GLYCOSEAMINOGLYCANES (GAG) WITH BIOLOGICALLY ACTIVE MOLECULES, POLYMER CONJUGATES AND THEIR RESPECTIVE APPLICATIONS | 2010 |
|
RU2530649C2 |
| PHARMACEUTICAL COMPOSITION WITH CYTOKINE AND IMMUNOMODULATING EFFECTS | 2002 |
|
RU2222345C2 |
| ANTI-ENTEROVIRAL AND IMMUNOSTIMULATING AGENT | 2014 |
|
RU2554761C1 |
